30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Clowes Howard

Insider profile

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Clowes Howard's trades of Plus Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-09-13 2024-09-11 B Purchase
40,929 +5.9%
16.14
US$4,898,884
40,929 +5.9% 16.14 US$4,898,884
2024-05-10 2024-05-08 B Purchase
74,764 +34.4%
479.10
US$1,610,271
74,764 +34.4% 479.10 US$1,610,271
2023-09-15 2023-09-13 B Purchase
3,727 -30.6%
67.47
US$4,522,305
3,727 -30.6% 67.47 US$4,522,305
2023-06-08 2023-06-06 B Purchase
1,000 +27.0%
3.98
US$3,980
1,000 +27.0% 3.98 US$3,980
2023-05-04 2023-05-03 B Purchase
2,500 +208.3%
3.64
US$9,102
2,500 +208.3% 3.64 US$9,102
2022-06-06 2022-06-02 B Purchase
15,000 +500.0%
0.57
US$8,589
15,000 +500.0% 0.57 US$8,589
2021-03-04 2021-03-03 B Purchase
3,000 +inf%
2.42
US$7,260
3,000 +inf% 2.42 US$7,260